首页 | 本学科首页   官方微博 | 高级检索  
     

多囊卵巢综合征胰岛素抵抗相关治疗进展
引用本文:徐洪丽,伍学焱. 多囊卵巢综合征胰岛素抵抗相关治疗进展[J]. 基础医学与临床, 2013, 33(2): 231-234
作者姓名:徐洪丽  伍学焱
作者单位:中国医学科学院北京协和医学院北京协和医院内分泌科卫生部内分泌重点实验室,北京,100730
基金项目:国家自然科学基金(81100416)
摘    要: 胰岛素抵抗(IR)是多囊卵巢综合征(PCOS)重要发病机制之一。临床上应用二甲双胍或噻唑烷二酮类药物可改善PCOS患者IR,纠正其代谢紊乱和高雄激素血症,故有助于恢复正常月经,增加排卵率及妊娠率,且孕期应用二甲双胍可能减少流产、妊娠高血压病、妊娠糖尿病等并发症。

关 键 词:多囊卵巢综合征  胰岛素抵抗  二甲双胍  噻唑烷二酮类药物  

Progress in treatment of insulin resistance in polycystic ovary syndrome
XU Hong-li,WU Xue-yan. Progress in treatment of insulin resistance in polycystic ovary syndrome[J]. Basic Medical Sciences and Clinics, 2013, 33(2): 231-234
Authors:XU Hong-li  WU Xue-yan
Affiliation:*(Key Laboratory of Endocrinology,Ministry of Health,Dept.of Endocrinology,PUMC Hospital,CAMS & PUMC,Beijing 100730,China)
Abstract:Insulin resistance plays a key role in the pathogenesis of polycystic ovary syndrome. Therefore thiazolidinediones and metformin, which have been used in clinical therapy to treat patients with polycystic ovary syndrome, can ameliorate insulin resistance,resulting in the improvement of some metabolic abnormalities, hyperandrogenic symptoms, menses, ovulation and pregnancy rates. Metformin therapy throughout pregnancy may reduce in pregnancy complications, such as miscarriage rate, gestational hypertension and gestational diabetes.
Keywords:polycystic ovary syndrome  insulin resistance  metformin  thiazolidinediones
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《基础医学与临床》浏览原始摘要信息
点击此处可从《基础医学与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号